Development of a nonhuman primate model for Trichomonas vaginalis infection

Sex Transm Dis. 2006 Dec;33(12):743-6. doi: 10.1097/01.olq.0000218871.89901.61.

Abstract

Objective: Trichomoniasis, caused by Trichomonas vaginalis, is a prevalent sexually transmitted infection associated with increased risk of HIV infection. An animal model of T. vaginalis infection would enable scientists to further investigate trichomoniasis.

Study design: Seven macaques (4 test vs. 3 control) were enrolled in a 2-week pilot study. Eight additional animals participated in a 2-arm (T. vaginalis vs. sham inoculated) crossover study lasting 5 weeks before treatment. In all, 12 Macaca nemestrina monkeys were challenged with a single intravaginal inoculation of 6.6 to 7.1 x 10(5) trichomonads (ATCC 50148). Vaginal culture (InPouch TV), colposcopy, microbiology, pH, and cervical cytokines were assessed at baseline, day 2, and weekly thereafter.

Results: Ten of 12 challenged animals tested positive for trichomoniasis for 2 weeks or longer. One animal tested positive on days 2 and 7 but negative thereafter. Only one animal was not infected. Oral metronidazole treatment (35 mg/kg per day for 3 days) resolved infection in all animals. Trichomoniasis infection did not lead to shifts in vaginal microbiology or pH.

Conclusions: A single T. vaginalis inoculation results in persistent infection in the pigtailed macaque.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Oral
  • Animals
  • Antiprotozoal Agents / administration & dosage
  • Antiprotozoal Agents / therapeutic use
  • Cross-Over Studies
  • Disease Models, Animal*
  • Drug Administration Schedule
  • Female
  • Macaca nemestrina
  • Metronidazole / administration & dosage
  • Metronidazole / therapeutic use
  • Trichomonas Vaginitis / drug therapy
  • Trichomonas Vaginitis / parasitology*
  • Trichomonas vaginalis / pathogenicity*

Substances

  • Antiprotozoal Agents
  • Metronidazole